Skip to content

OSSIX™ Bone 0.500 ccRecalls & reported problems

Datum Dental Ltd · OSSIX™ BONE is a biodegradable, osteoconductive, and biocompatible bone grafting material intended for guided tissue and bone regeneration. The OSSIX™ BONE matrix is composed of 80% synthetic crystalline non-sintered hydroxylapatite and 20% collagen, which is derived from veterinary certified pigs and is purified and cross-linked. · Class 2 · Implant

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07290015477253), received between Oct 11, 2022 and Oct 22, 2025 — classified as 2 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate1
  • Use of Device Problem1

Patient problems

  • Difficulty Chewing1
  • Insufficient Information1
  • Osteomyelitis1
  • Swelling/ Edema1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 22, 2025Failure to Osseointegrate; Failure to Osseointegrate

    IN THIS EVENT IT IS REPORTED THAT OSSIX BONE 5*10*10 (0.5 CC) WAS USED IN TREATMENT. CUSTOMER REPORTS THAT WHEN THE AREA WAS REOPENED AFTER 6 MONTHS, NO BONE FORMED. THE PRODUCT REMAINS SPONGY/RUBBERY. THIS IS A OSSEOINTEGRATION ISSUE.

    Patient problems: Insufficient Information

    MAUDE report 23356382 ↗
  • InjuryOct 11, 2022Use of Device Problem; Use of Device Problem

    A DOCTOR REPORTED THAT THEY REMOVED TEETH 15-16 AND PLACED OSSIX BONE IN A SOCKET PRESERVATION PROCEDURE. THE DOCTOR DID NOT HYDRATE THE MATERIAL PRIOR TO PLACEMENT. THE PATIENT INDICATED 3 DAYS POST PROCEDURE THAT THEY DEVELOPED SWELLING AND WERE PRESCRIBED AMOXICILLIN. AT THE ONE-WEEK POST-OP VISIT, THE DOCTOR NOTED SLIGHT SWELLING AND PRESCRIBED THE PATIENT MEDROL DOSE PACK. LATER THE PATIENT CALLED TO INDICATE THEIR JAW FELT STIFF AND THEY WERE PRESCRIBED CYCLOBENZAPRINE MUSCLE RELAXANT. THE PATIENT LATER DEVELOPED SWELLING AT THE ANGLE OF HER MANDIBLE AND WAS INSTRUCTED TO GO TO THE EMERGENCY ROOM BY TREATING DOCTOR. THE TREATING DOCTOR AT THE ER DIAGNOSED THE PATIENT WITH OSTEOMYELITIS AND THEY WERE REFERRED TO AN INFECTIOUS DISEASE SPECIALIST WHO PLACED THE PATIENT ON IV ANTIBIOTICS THERAPY FOR 2 DAYS. THE PATIENT RETURNED TO THE REPORTING OFFICE APPROXIMATELY ONE MONTH POST PROCEDURE TO BE SEEN BY THE MAXILLOFACIAL SURGEON AND THEY NOTED THERE WERE NO SIGNS OF OSTEOMYELITIS. THE WOUND WAS REOPENED AND THE OFFICE PERFORMED AN IRRIGATION AND DEBRIDEMENT. THE TREATING OFFICE INDICATED, THE PATIENT HAS NOT FOLLOWED UP WITH THE INFECTIOUS DISEASE SPECIALIST AND IS NOT TAKING THE

    Patient problems: Difficulty Chewing; Osteomyelitis; Swelling/ Edema

    MAUDE report 15577264 ↗

Other Bone Grafting Material, Animal Source devices

All Bone Grafting Material, Animal Source devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.